Authors



Betty Parker

Latest:

The importance of pre-call planning

Pre-call planning is a necessity if you're going to move your physicians and your productivity to another level.


Gaurav Kapoor

Latest:

Biopharma Trends in 2024 and Beyond

Generative artificial intelligence, key new product launches, and the evolution of the go-to-market model are among key trends to watch in the year ahead.



Peter Spellman, Supplyscape

Latest:

e-Pedigree to the Next Degree

Electronic pedigree is the future of supply chain security. Those still waiting and seeing might what to stop waiting and start tracking


Matthew Herman

Latest:

Salesforce Roundtable

Industry insiders explain how pharma companies are reorganizing their salesforces in the wake of industry-wide layoffs


Gil Bashe

Latest:

Emotion - The New Brand Integrator

Driven by the quest for innovation, the intensity of competition, and the pressure to create megabrands and megamergers, pharmaceutical executives are exploring an influential force still untapped by most marketing and communication departments-the power of emotion.




Paul Tebbey

Latest:

The Holy Grail of Product Development

Defining, evaluating, and utilizing the Target Product Profile.


Lisa Flaiz, Razorfish

Latest:

The Future of Media and Social Influence Marketing

Communications planning in 2009 and beyond will include online, offline, mobile, out-of-home, point-of-sale, gaming consoles, and more-even your car's navigation system will be tied to Google! Perhaps most importantly, communications planning will begin to include social influence marketing.


Pieter Sheth-Voss

Latest:

Putting Predictive Market Research to the Test

There's a temptation for companies to view predictive markets as a silver bullet. Can crowds actually do a better job than "experts," or is that viewpoint more of a fad than a foundation for accurate future forecasting?


Christopher E. McCarthy, MD, FACP

Latest:

Top 10 Detailing Pitfalls

Competition for physicians' time has become so intense that some medical groups have severely restricted or banned reps altogether. Part of that strained relationship can be traced back to some of the sales techniques used by aggressive pharma salespeople. Physicians have become wary of being "sold" and often do not trust the information reps provide. Many doctors no longer feel that sales reps help provide better care for patients. Rather, physicians often come away feeling as though they just had an encounter with a used car dealer. To improve their relationships with medical professionals, pharma sales reps should avoid ten



Richard Pinsky

Latest:

Five commandments of business writing

Tips to help your written communications.


Paul da Costa

Latest:

Wyeth V. Levine: An Attorneys' Perspective

Lawyers from Duane Morris LLP offer their take on the Supreme Court's groundshaking preemption decision




Fred Kelly

Latest:

Part 3: How to Enforce Post-Employment Restrictions

Courts are often hesitant to enforce such restrictions, so employers should take certain steps prior to and in the process of filing such a lawsuit.


David Williams

Latest:

How Do You Solve a Problem Like Manufacturing?

Outsourcing saves money-except when it doesn't. Here's how to decide what to do.


Terry Stone

Latest:

Goodbye, Willy Loman

The days of pharma sales reps going office-to-office with samples and brochures are done. These days, they need to turn their attention to payers, pharmacists, and consumers


James A. Dutton

Latest:

Education Trumps Regulation

New research points to the power of a highly educated sales force, supporting the case for a voluntary educational standard



Rich Bailey

Latest:

A New Game Plan for Pharma HR

New dynamics are forcing the industry's human resource departments to rethink their operational game plans. The drivers-consolidation, globalization, scientific advances, public policy, and competition-have pushed HR leaders into new territory to address business needs.


Paul E. Kalb

Latest:

Where Caremark Meets Park: A New Era of Regulatory Compliance and Criminal Liability

The Caremark and Park doctrines require directors and managers of life sciences companies to address regulatory compliance proactively and vigorously.



Margaret Mueller, Leo J. Shapiro & Associates

Latest:

Earning the Public Trust—and Keeping It

The industry needs credibility with consumers to make a spoonful of risk go down. So how does pharma speak to top concerns?




Jeff Gilbreth

Latest:

Part 3: How to Enforce Post-Employment Restrictions

Courts are often hesitant to enforce such restrictions, so employers should take certain steps prior to and in the process of filing such a lawsuit.

© 2025 MJH Life Sciences

All rights reserved.